Clinical Trial Update: A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial sponsored by Novo Nordisk is evaluating different doses of CDR132L versus placebo for heart failure with preserved ejection fraction an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Preserved Ejection Fraction
• Left Ventricular Hypertrophy

Drugs mentioned

• CDR132L

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Heart Failure | Phase 2 | Status: RECRUITING